GALPHARM Loratadine 10mg Hayfever and Allergy Relief One-a-Day Tablets 14's

Product Information

The contact can be with your skin, mouth, gullet (oesophagus), stomach, intestine or with the lining of your lungs.

Galpharm Cetirizine Hayfever and Allergy Relief Tablets

The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased. If you’re allergic to a particular allergen, you may suffer from a mild cough or a sneeze attack – but for others the symptoms can be much more severe and can even lead to death. The other ingredients are: Lactose, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate, hypromellose (E464), macrogol, titanium dioxide (E171) and polydextrose.

Substances in the environment that cause the response are known as allergens, and someone who suffers a response to a particular allergen is said to be allergic to it.

Allergy Relief 30 Pack - Tesco Groceries Treathay Allergy Relief 30 Pack - Tesco Groceries

The extent of bioavailability is similar when cetirizine is given as solutions, capsules or tablets. Allergy skin tests are inhibited by antihistamines and a wash-out period (of 3 days) is required before performing them. Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.At the recommended dosage, cetirizine has demonstrated that it improves the quality of life of patients with perennial and seasonal allergic rhinitis. This might include changes to allergy advice, ingredient lists, nutritional guides or dietary advice. In addition to the adverse reactions reported during clinical studies and listed above, the following undesirable effects have been reported in post-marketing experience. In paediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance of the patient, his age and his body weight. Patients with moderate renal impairment had a 3-fold increase in half-life and 70 % decrease in clearance compared to healthy volunteers.